RXMD Stock Overview
Progressive Care, Inc. operates as a healthcare services and technology company in south Florida.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Progressive Care, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$1.85 |
52 Week High | US$6.05 |
52 Week Low | US$0.40 |
Beta | -0.25 |
1 Month Change | -21.28% |
3 Month Change | -37.31% |
1 Year Change | -43.94% |
3 Year Change | -90.70% |
5 Year Change | -84.96% |
Change since IPO | -92.29% |
Recent News & Updates
Recent updates
Shareholder Returns
RXMD | US Consumer Retailing | US Market | |
---|---|---|---|
7D | -2.6% | -2.0% | -3.7% |
1Y | -43.9% | 15.1% | 20.5% |
Return vs Industry: RXMD underperformed the US Consumer Retailing industry which returned 16.1% over the past year.
Return vs Market: RXMD underperformed the US Market which returned 20.2% over the past year.
Price Volatility
RXMD volatility | |
---|---|
RXMD Average Weekly Movement | 18.0% |
Consumer Retailing Industry Average Movement | 4.6% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.4% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: RXMD's share price has been volatile over the past 3 months.
Volatility Over Time: RXMD's weekly volatility (18%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | 143 | Charles Fernandez | progressivecareus.com |
Progressive Care, Inc. operates as a healthcare services and technology company in south Florida. The company provides prescription pharmaceuticals; COVID-19 related diagnostics and vaccinations; compounded medications; tele-pharmacy services; anti-retroviral medications; medication therapy management; and medication adherence packaging and contracted pharmacy services. It also supplies various prescription medications to long term care facilities.
Progressive Care, Inc. Fundamentals Summary
RXMD fundamental statistics | |
---|---|
Market cap | US$11.86m |
Earnings (TTM) | -US$14.65m |
Revenue (TTM) | US$49.73m |
0.2x
P/S Ratio-0.8x
P/E RatioIs RXMD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
RXMD income statement (TTM) | |
---|---|
Revenue | US$49.73m |
Cost of Revenue | US$34.57m |
Gross Profit | US$15.16m |
Other Expenses | US$29.81m |
Earnings | -US$14.65m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -2.35 |
Gross Margin | 30.49% |
Net Profit Margin | -29.46% |
Debt/Equity Ratio | 4.7% |
How did RXMD perform over the long term?
See historical performance and comparison